Alcohol use among people who inject drugs living with HIV in Kenya is associated with needle sharing, more new sex partners, and lower engagement in HIV care.
Alcohol
Care engagement
HIV
HIV risk behaviors
Injection drug use
Kenya
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
accepted:
06
06
2023
pubmed:
15
6
2023
medline:
15
6
2023
entrez:
15
6
2023
Statut:
ppublish
Résumé
We assessed the prevalence and correlates of alcohol use among 870 people who inject drugs living with HIV in Kenya, with attention toward (1) sexual and injecting risk behaviors for HIV transmission and (2) HIV care engagement. We defined heavy alcohol use as > 14 drinks/week for men and > 7 drinks/week for women, moderate alcohol use as any lesser but non-zero amount, and any alcohol use as either moderate or heavy use. Approximately 39% of participants reported any alcohol use and 15% heavy use. In multivariate analysis, any alcohol use compared to no use was associated with needle sharing, > 3 new sex partners in the past 3 months, being unaware of HIV status, never enrolling in HIV care, and not being on ART (all p < 0.05). Heavy alcohol use as compared to no use was associated with needle sharing (aOR = 2.72; 95% CI 1.43, 5.13), injection equipment sharing (aOR = 1.80; 95% CI 1.00, 3.16), > 3 new sex partners in the past 3 months (aOR = 1.99; 95% CI 1.12, 3.49), and being unaware of HIV status (aOR = 2.77; 95% CI 1.46, 5.19). There was no association between any measure of alcohol use and unsuppressed viral load. Alcohol use among people who inject drugs living with HIV may carry elevated risk of HIV transmission mediated by sexual and injecting practices and is associated with lower engagement in multiple stages of the HIV care cascade.
Identifiants
pubmed: 37318665
doi: 10.1007/s10461-023-04113-0
pii: 10.1007/s10461-023-04113-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3970-3980Subventions
Organisme : NIDA NIH HHS
ID : R01 DA043409
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA043409
Pays : United States
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Degenhardt L, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–207.
pubmed: 29074409
pmcid: 5683738
doi: 10.1016/S2214-109X(17)30375-3
Mathers BM, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.
pubmed: 18817968
doi: 10.1016/S0140-6736(08)61311-2
National AIDS, Control Programme STI. KENPHIA 2018 preliminary Report. NASCOP: Nairobi; 2020.
National AIDS, Control Programme STI. Kenya Most at Risk populations size Estimate Consensus. NASCOP: Nairobi; 2013.
Kurth AE, et al. Prevalence, estimated incidence, and risk behaviors among people who inject drugs in Kenya. J Acquir Immune Defic Syndr. 2015;70(4):420–7.
pubmed: 26226249
pmcid: 4624615
doi: 10.1097/QAI.0000000000000769
Brodish P, et al. Evidence of high-risk sexual behaviors among injection drug users in the Kenya PLACE study. Drug Alcohol Depend. 2011;119(1–2):138–41.
pubmed: 21700402
pmcid: 3210477
doi: 10.1016/j.drugalcdep.2011.05.030
Oguya FO, et al. Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey. BMC Public Health. 2021;21(1):1549.
pubmed: 34391389
pmcid: 8364050
doi: 10.1186/s12889-021-11373-9
Musyoki H, et al. A decade and beyond: learnings from HIV programming with underserved and marginalized key populations in Kenya. J Int AIDS Soc. 2021;24(Suppl 3):e25729.
pubmed: 34189847
pmcid: 8242977
doi: 10.1002/jia2.25729
Powell A, et al. Subjective executive function deficits in hazardous alcohol drinkers. J Psychopharmacol. 2021;35(11):1375–85.
pubmed: 34278885
pmcid: 8600595
doi: 10.1177/02698811211032605
Le Marchand C, et al. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug Alcohol Depend. 2013;127(1–3):143–9.
pubmed: 22819868
doi: 10.1016/j.drugalcdep.2012.06.024
Fisher JC, Bang H, Kapiga SH. The association between HIV infection and alcohol use: a systematic review and meta-analysis of african studies. Sex Transm Dis. 2007;34(11):856–63.
pubmed: 18049422
doi: 10.1097/OLQ.0b013e318067b4fd
Noroozi M, et al. Effect of Alcohol Use on Injection and sexual behavior among people who inject drugs in Tehran, Iran: a coarsened exact matching Approach. J Res Health Sci. 2018;18(2):e00416.
pubmed: 29784897
Scott-Sheldon LA, et al. Alcohol use and sexual risk behaviors among individuals infected with HIV: a systematic review and meta-analysis 2012 to early 2013. Curr HIV/AIDS Rep. 2013;10(4):314–23.
pubmed: 24078370
pmcid: 3946916
doi: 10.1007/s11904-013-0177-5
Matos TD, et al. HIV risk behaviors and alcohol intoxication among injection drug users in Puerto Rico. Drug Alcohol Depend. 2004;76(3):229–34.
pubmed: 15561474
doi: 10.1016/j.drugalcdep.2004.05.007
Stein MD, et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat. 2000;18(4):359–63.
pubmed: 10812309
doi: 10.1016/S0740-5472(99)00070-7
Rees V, et al. Association of alcohol consumption with HIV sex- and drug-risk behaviors among drug users. J Subst Abuse Treat. 2001;21(3):129–34.
pubmed: 11728786
doi: 10.1016/S0740-5472(01)00190-8
Vagenas P, et al. The impact of Alcohol Use and Related Disorders on the HIV Continuum of Care: a systematic review: Alcohol and the HIV Continuum of Care. Curr HIV/AIDS Rep. 2015;12(4):421–36.
pubmed: 26412084
pmcid: 4643391
doi: 10.1007/s11904-015-0285-5
Azar MM, et al. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–93.
pubmed: 20705402
pmcid: 2997193
doi: 10.1016/j.drugalcdep.2010.06.014
Chang GC, et al. Hazardous alcohol use and HIV indicators in six african countries: results from the Population-based HIV Impact assessments, 2015–2017. J Int AIDS Soc. 2022;25(11):e26029.
pubmed: 36408717
pmcid: 9677379
doi: 10.1002/jia2.26029
Puryear SB, et al. Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa. AIDS. 2020;34(3):405–13.
pubmed: 31725431
doi: 10.1097/QAD.0000000000002427
Myers B, et al. Associations between patterns of Alcohol Use and viral load suppression Amongst Women living with HIV in South Africa. AIDS Behav. 2021;25(11):3758–69.
pubmed: 33876383
pmcid: 8560660
doi: 10.1007/s10461-021-03263-3
Vinikoor MJ et al. Intersection of alcohol use, HIV infection, and the HIV care continuum in Zambia: nationally representative survey. AIDS Care, 2022: p. 1–8.
Long JE, et al. Alcohol use and viral suppression in HIV-positive kenyan female sex workers on antiretroviral therapy. PLoS ONE. 2020;15(11):e0242817.
pubmed: 33232378
pmcid: 7685481
doi: 10.1371/journal.pone.0242817
Wagman JA, et al. Hazardous alcohol use, antiretroviral therapy receipt, and viral suppression in people living with HIV who inject drugs in the United States, India, Russia, and Vietnam. AIDS. 2020;34(15):2285–94.
pubmed: 33048870
doi: 10.1097/QAD.0000000000002716
Arasteh K, Des DC, Jarlais. At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City. AIDS Patient Care STDS. 2009;23(8):657–61.
pubmed: 19591610
pmcid: 2832647
doi: 10.1089/apc.2009.0027
Chavez K, et al. Hazardous alcohol Use, Impulsivity, and HIV-Risk Behavior among HIV-Positive russian patients with a history of Injection Drug Use. Am J Addict. 2021;30(2):164–72.
pubmed: 33378082
doi: 10.1111/ajad.13112
Li L, et al. Alcohol Use, HIV Treatment Adherence, and sexual risk among people with a history of Injecting Drug Use in Vietnam. AIDS Behav. 2017;21(Suppl 2):167–73.
pubmed: 28726041
pmcid: 5660660
doi: 10.1007/s10461-017-1860-0
Ludwig-Barron NT, et al. Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators. Harm Reduct J. 2021;18(1):133.
pubmed: 34922548
pmcid: 8684158
doi: 10.1186/s12954-021-00580-7
Bruce RD, et al. Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment. Int J Drug Policy. 2014;25(1):22–5.
pubmed: 24210295
doi: 10.1016/j.drugpo.2013.09.005
Kurth AE, et al. The opioid epidemic in Africa and its impact. Curr Addict Rep. 2018;5(4):428–53.
pubmed: 32494564
pmcid: 7269163
doi: 10.1007/s40429-018-0232-9
Monroe-Wise, A., et al., Peer-mediated HIV assisted partner services to identify and link to care HIV-positive and HCV-positive people who inject drugs: a cohort study protocol. BMJ Open, 2021. 11(4): p. e041083.
Steiner A, et al. Managing research and surveillance projects in real-time with a novel open-source eManagement tool designed for under-resourced countries. J Am Med Inform Assoc. 2016;23(5):916–23.
pubmed: 26911813
doi: 10.1093/jamia/ocv185
Papas RK, et al. Estimating alcohol content of traditional brew in Western Kenya using culturally relevant methods: the case for cost over volume. AIDS Behav. 2010;14(4):836–44.
pubmed: 19015972
doi: 10.1007/s10461-008-9492-z
National Center for Chronic Disease Prevention and Health. Excessive Alcohol Use. Center for Disease Control and Prevention; 2021.
National Institute on Alcohol Abuse and Alcoholism. Drinking levels defined. National Institutes of Health; 2022.
Patel NB. Khat (Catha edulis Forsk) - and now there are three. Brain Res Bull. 2019;145:92–6.
pubmed: 30059706
doi: 10.1016/j.brainresbull.2018.07.014
World Health Organization., Consolidated strategic information guidelines for HIV in the health sector. 2015.
UNAIDS. Global AIDS Response Progress Reporting 2016: construction of core indicators for monitoring the 2011 United Nations Political Declaration on HIV and AIDS. Geneva; 2016.
Centers for Disease Control and Prevention. Understanding the HIV Care Continuum. Atlanta, GA: CDC; 2017.
Joint United Nations Programme on HIV/AIDS. Miles to go: closing gaps, breaking barriers, righting injustices. UNAIDS: Geneva; 2018.
Kadere T, et al. Traditional tapping and distillation methods of coconut wine (mnazi) as practiced in the Coastal region of Kenya. African Journal of Food Agriculture Nutrition and Development; 2004.
Kibwage I, Maitai C, Mureithi I. Alcohol Content of Traditional Brews and Miti ni Dawa in Kenya. 1998, East and Central African Journal of Pharmaceutical Sciences. p. 54–57.
Giordano TP, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005;17(6):773–83.
pubmed: 16036264
doi: 10.1080/09540120412331336652
Maughan-Brown B, et al. Poor rates of linkage to HIV care and uptake of treatment after home-based HIV testing among newly diagnosed 15-to-49 year-old men and women in a high HIV prevalence setting in South Africa. AIDS Care. 2021;33(1):70–9.
pubmed: 32036678
doi: 10.1080/09540121.2020.1719025
Heestermans T, et al. Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-saharan Africa: a systematic review. BMJ Glob Health. 2016;1(4):e000125.
pubmed: 28588979
pmcid: 5321378
doi: 10.1136/bmjgh-2016-000125
National Authority for the Campaign Against Alcohol and Drug Abuse. Rapid Situation Assessment of drugs and substance abuse in Kenya. NACADA: Nairobi; 2017.
Pengpid S, Peltzer K. Alcohol use among adults in Kenya: Results from the National Non-Communicable Diseases Risk Factor survey. 2015, Journal of Psychology in Africa. p. 49–53.
World Health Organization. Global Status Report on Alcohol. WHO: Geneva; 2018.
Willis J. Soured Wine: The Development and Suppression of the Palm Wine Economy in Kenya, in Kenya Past and Present. p. 35–39.
Witkiewitz K, Litten RZ, Leggio L. Adv Sci Treat alcohol use disorder Sci Adv. 2019;5(9):eaax4043.
pubmed: 31579824
Chepkwony S, Chelule E, Barmao A. An investigation into prevalence and factors contributing to relapse among alcoholics In Selected Rehabilitation Centres in Nairobi County, Kenya. 2013, International Journal of Research and Development.
McGinnis KA, et al. Impact of behavioral and medication treatment for alcohol use disorder on changes in HIV-related outcomes among patients with HIV: a longitudinal analysis. Drug Alcohol Depend. 2020;217:108272.
pubmed: 32971391
pmcid: 7757793
doi: 10.1016/j.drugalcdep.2020.108272